This company listing is no longer active
Salud financiera de hoja de balance de Yourgene Health
Salud financiera controles de criterios 3/6
Yourgene Health has a total shareholder equity of £26.0M and total debt of £4.1M, which brings its debt-to-equity ratio to 15.7%. Its total assets and total liabilities are £54.8M and £28.8M respectively.
Información clave
15.7%
Ratio deuda-patrimonio
UK£4.10m
Deuda
| Ratio de cobertura de intereses | n/a |
| Efectivo | UK£2.40m |
| Patrimonio | UK£26.03m |
| Total pasivo | UK£28.78m |
| Activos totales | UK£54.81m |
Actualizaciones recientes sobre salud financiera
Recent updates
Yourgene Health Plc (LON:YGEN) Shares Could Be 34% Above Their Intrinsic Value Estimate
Sep 22
Is There An Opportunity With Yourgene Health Plc's (LON:YGEN) 35% Undervaluation?
Apr 15We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Yourgene Health Plc's (LON:YGEN) CEO For Now
Sep 22Estimating The Intrinsic Value Of Yourgene Health Plc (LON:YGEN)
Aug 07Does This Valuation Of Yourgene Health Plc (LON:YGEN) Imply Investors Are Overpaying?
Feb 25What Did Yourgene Health's (LON:YGEN) CEO Take Home Last Year?
Jan 27What Kind Of Shareholders Hold The Majority In Yourgene Health Plc's (LON:YGEN) Shares?
Dec 22Análisis de la situación financiera
Pasivos a corto plazo: YGEN's short term assets (£13.0M) exceed its short term liabilities (£9.5M).
Pasivo a largo plazo: YGEN's short term assets (£13.0M) do not cover its long term liabilities (£19.3M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: YGEN's net debt to equity ratio (6.5%) is considered satisfactory.
Reducción de la deuda: YGEN's debt to equity ratio has reduced from 397.8% to 15.7% over the past 5 years.
Hoja de balance
Análisis de cash runway
En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.
Cash runway estable: Insufficient data to determine if YGEN has enough cash runway based on its current free cash flow.
Pronóstico de cash runway: Insufficient data to determine if YGEN has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.